Incyte Corp Earnings Estimate

INCY -  USA Stock  

USD 75.34  0.55  0.74%

Many public companies, such as Incyte Corp, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Incyte Corp's earnings estimates, investors can diagnose different trends across Incyte Corp's analyst sentiment over time as well as compare current estimates against different timeframes.
Incyte Corp is projected to generate 2.66 in earnings per share on the 31st of December 2021. Incyte Corp earnings estimates module stress-tests analyst consensus about projected Incyte Corp EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Please see Risk vs Return Analysis.

Incyte Earnings Estimates 

 
Refresh
Gross Profit is likely to rise to about 3.1 B in 2022

Incyte Corp Earnings Estimation Breakdown

Calculation of earning per share of Incyte Corp is based on official Zacks consensus of 3 analysts regarding Incyte Corp future annual earnings. Given the historical accuracy of 70.97%, the future earnings per share of Incyte Corp is estimated to be 2.66 with the lowest and highest values of 2.38 and 2.89, respectively. Please note that this consensus of annual earnings estimates for Incyte Corp is an estimate of EPS before non-recurring items and including employee stock options expenses
Current EPS
2.41
24th of January 2022
2.38
Lowest
Estimated EPS
2.66
2.89
Highest

Incyte Corp Earnings Projection Consensus

Suppose the current estimates of Incyte Corp's value are higher than the current market price of the Incyte Corp stock. In this case, investors may conclude that Incyte Corp is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Incyte Corp's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

3

70.97%

2.41

2.66

Incyte Corp Earnings History

Earnings estimate consensus by Incyte Corp analysts from Wall Street is used by the market to judge Incyte Corp's stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Incyte Corp's upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Incyte Corp Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

224.6 MillionShare
Accumulated Retained Earnings Deficit is likely to drop to about (1.7 B) in 2022. Earning Before Interest and Taxes EBIT is likely to drop to about (271.5 M) in 2022 Issuance Purchase of Equity Shares is likely to rise to about 141.4 M in 2022, whereas Weighted Average Shares is likely to drop slightly above 235.6 M in 2022.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Incyte Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Incyte Corp in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
71.4673.6675.86
Details
Intrinsic
Valuation
LowReal ValueHigh
66.2484.9187.11
Details
Naive
Forecast
LowNext ValueHigh
73.5875.7877.97
Details
14 Analysts
Consensus
LowTarget PriceHigh
66.0088.42109.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Incyte Corp. Your research has to be compared to or analyzed against Incyte Corp's peers to derive any actionable benefits. When done correctly, Incyte Corp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Incyte Corp.
Note that many institutional investors and large investment bankers can move markets due to the volume of Incyte assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Incyte Corp. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Incyte stock price in the short term.

Incyte Corp Earnings per Share Projection vs Actual

Actual Earning per Share of Incyte Corp refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Incyte Corp predict the company's earnings will be in the future. The higher the earnings per share of Incyte Corp, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Incyte Corp Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Incyte Corp, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Incyte Corp should always be considered in relation to other companies to make a more educated investment decision.

Incyte Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Incyte Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-11-02
2021-09-300.761.180.4255 
2021-08-03
2021-06-300.740.80.06
2021-05-04
2021-03-310.64270.670.0273
2021-02-09
2020-12-310.76640.930.163621 
2020-11-05
2020-09-300.75690.23-0.526969 
2020-08-04
2020-06-300.86311.240.376943 
2020-05-05
2020-03-31-2.7975-2.86-0.0625
2020-02-13
2019-12-310.57620.650.073812 
2019-10-29
2019-09-300.63980.820.180228 
2019-07-30
2019-06-300.4970.750.25350 
2019-04-30
2019-03-310.41470.620.205349 
2019-02-14
2018-12-310.48690.4-0.086917 
2018-10-30
2018-09-300.40530.38-0.0253
2018-07-31
2018-06-300.21750.260.042519 
2018-05-01
2018-03-310.1061-0.01-0.1161109 
2018-02-15
2017-12-31-0.3264-0.71-0.3836117 
2017-10-31
2017-09-300.0640.170.106165 
2017-08-01
2017-06-30-0.035-0.06-0.02571 
2017-05-04
2017-03-31-0.88-0.96-0.08
2017-02-14
2016-12-310.14090.05-0.090964 
2016-11-01
2016-09-300.01670.190.17331037 
2016-08-09
2016-06-30-0.02310.180.2031879 
2016-05-09
2016-03-310.26670.12-0.146755 
2016-02-11
2015-12-310.17390.28770.113865 
2015-11-03
2015-09-30-0.41-0.220.1946 
2015-08-04
2015-06-30-0.110.050.16145 
2015-04-30
2015-03-31-0.1-0.11-0.0110 
2015-02-12
2014-12-31-0.09-0.22-0.13144 
2014-10-30
2014-09-300.010.330.323200 
2014-07-31
2014-06-30-0.04-0.22-0.18450 
2014-05-01
2014-03-31-0.18-0.21-0.0316 
2014-02-12
2013-12-31-0.11-0.15-0.0436 
2013-10-31
2013-09-30-0.13-0.14-0.01
2013-08-01
2013-06-300.080.05-0.0337 
2013-05-02
2013-03-31-0.19-0.120.0736 
2013-02-14
2012-12-31-0.020.140.16800 
2012-11-01
2012-09-30-0.21-0.170.0419 
2012-08-02
2012-06-30None0.03None
2012-04-26
2012-03-31-0.46-0.360.121 
2012-02-15
2011-12-31-0.39-0.44-0.0512 
2011-10-27
2011-09-30-0.45-0.420.03
2011-07-28
2011-06-30-0.36-0.41-0.0513 
2011-05-03
2011-03-31-0.32-0.210.1134 
2011-02-10
2010-12-310.190.240.0526 
2010-11-09
2010-09-30-0.32-0.260.0618 
2010-08-05
2010-06-30-0.040.020.06150 
2010-05-06
2010-03-31-0.32-0.30.02
2010-02-18
2009-12-31-0.36-0.41-0.0513 
2009-11-05
2009-09-30-0.4-0.44-0.0410 
2009-07-30
2009-06-30-0.41-0.410
2009-05-07
2009-03-31-0.41-0.410
2009-02-18
2008-12-31-0.48-0.5-0.02
2008-11-06
2008-09-30-0.5-0.480.02
2008-07-29
2008-06-30-0.5-0.54-0.04
2008-04-30
2008-03-31-0.47-0.470
2008-02-14
2007-12-31-0.28-0.260.02
2007-11-01
2007-09-30-0.27-0.29-0.02
2007-07-26
2007-06-30-0.27-0.220.0518 
2007-05-03
2007-03-31-0.26-0.260
2007-02-15
2006-12-31-0.25-0.240.01
2006-11-02
2006-09-30-0.24-0.190.0520 
2006-07-27
2006-06-30-0.24-0.240
2006-05-04
2006-03-31-0.26-0.210.0519 
2006-02-16
2005-12-31-0.31-0.33-0.02
2005-11-01
2005-09-30-0.38-0.360.02
2005-08-01
2005-06-30-0.33-0.30.03
2005-05-04
2005-03-31-0.33-0.240.0927 
2005-02-28
2004-12-31-0.35-0.47-0.1234 
2004-11-04
2004-09-30-0.43-0.350.0818 
2004-08-04
2004-06-30-0.4-0.87-0.47117 
2004-05-04
2004-03-31-0.45-0.52-0.0715 
2004-02-02
2003-12-31-0.49-0.56-0.0714 
2003-11-04
2003-09-30-0.39-0.6-0.2153 
2003-07-30
2003-06-30-0.39-0.370.02
2003-05-05
2003-03-31-0.28-0.36-0.0828 
2003-02-19
2002-12-31-0.39-0.45-0.0615 
2002-11-12
2002-09-30-0.37-0.45-0.0821 
2002-07-25
2002-06-30-0.28-0.260.02
2002-05-01
2002-03-31-0.21-0.20.01
2002-02-13
2001-12-31-0.76-0.220.5471 
2001-10-25
2001-09-30-0.19-0.27-0.0842 
2001-07-19
2001-06-30-0.23-0.150.0834 
2001-04-25
2001-03-31-0.28-0.160.1242 
2001-02-01
2000-12-31-0.12-0.110.01
2000-10-17
2000-09-30-0.12-0.120
2000-07-18
2000-06-30-0.22-0.10.1254 
2000-04-19
2000-03-31-0.28-0.130.1553 
2000-01-26
1999-12-31-0.12-0.110.01
1999-10-19
1999-09-30-0.19-0.190
1999-07-14
1999-06-30-0.11-0.110
1999-04-21
1999-03-31-0.08-0.040.0450 
1999-02-03
1998-12-310.10.120.0220 
1998-10-14
1998-09-300.10.08-0.0220 
1998-07-14
1998-06-300.090.10.0111 
1998-04-08
1998-03-310.080.080
1998-01-13
1997-12-310.070.090.0228 
1997-10-15
1997-09-300.060.060
1997-07-15
1997-06-300.040.040
1997-04-17
1997-03-310.030.02-0.0133 
1997-02-26
1996-12-310.010.010
1996-10-24
1996-09-30-0.0100.01100 
1996-07-25
1996-06-30-0.03-0.04-0.0133 
1996-04-25
1996-03-31-0.04-0.040

About Incyte Corp Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Incyte Corp earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Incyte Corp estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Incyte Corp fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit-1.6 B-1.7 B
Earning Before Interest and Taxes EBIT-264.6 M-271.5 M
Earnings per Basic Share(1.56) (1.61) 
Earnings per Diluted Share(1.56) (1.61) 
Price to Earnings Ratio(57.56) (59.07) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-205 M-210.4 M
Earnings before Tax-267.1 M-274.1 M
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. Incyte Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1773 people.

Incyte Corp Investors Sentiment

The influence of Incyte Corp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Incyte. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Incyte Corp Implied Volatility

    
  44.83  
Incyte Corp's implied volatility exposes the market's sentiment of Incyte Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Incyte Corp's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Incyte Corp stock will not fluctuate a lot when Incyte Corp's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Incyte Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Incyte Corp's short interest history, or implied volatility extrapolated from Incyte Corp options trading.

Current Sentiment - INCY

Incyte Corp Investor Sentiment

Majority of Macroaxis users are currently bullish on Incyte Corp. What is your judgment towards investing in Incyte Corp? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Incyte Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Incyte Corp information on this page should be used as a complementary analysis to other Incyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Incyte Stock analysis

When running Incyte Corp price analysis, check to measure Incyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte Corp is operating at the current time. Most of Incyte Corp's value examination focuses on studying past and present price action to predict the probability of Incyte Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Incyte Corp's price. Additionally, you may evaluate how the addition of Incyte Corp to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Is Incyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte Corp. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Incyte Corp is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte Corp's value that differs from its market value or its book value, called intrinsic value, which is Incyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte Corp's market value can be influenced by many factors that don't directly affect Incyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Incyte Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.